PrEP: latest news

PrEP resources

  • How to get PrEP in the UK

    NHS services in the UK cannot currently provide PrEP.But it is legal to buy PrEP drugs online and import them for your personal use.To use PrEP safely, you...

    From: Factsheets

    Information level Level 2
  • Pre-exposure prophylaxis (PrEP)

    PrEP is highly effective in preventing the sexual transmission of HIV. For PrEP to work well, it’s important to take the pills regularly.While PrEP can...

    From: Factsheets

    Information level Level 2
  • Using anti-HIV drugs to prevent HIV

    The goal of HIV treatment is an undetectable viral load. An undetectable viral load means that your blood has a level of HIV below the level which...

    From: Booklets

    Information level Level 2
  • PrEP

    This briefing paper provides an overview of pre-exposure prophylaxis (PrEP) for people planning, commissioning or providing HIV prevention activities in the UK. It does this by reviewing...

    From: HIV prevention briefing papers

  • Pre-exposure prophylaxis

    Pre-exposure prophylaxis is an experimental HIV-prevention strategy that would use antiretrovirals (ARVs) to protect HIV-negative people from HIV infection....

    From: Preventing HIV

    Information level Level 4

PrEP features

PrEP news from aidsmap

More news

PrEP news selected from other sources

  • Melbourne man tests positive to HIV while taking preventative drug

    A man has tested positive to HIV at a Melbourne clinic while participating in a trial of PrEP, an antiretroviral drug credited with preventing the spread of the disease. It's understood just over a week ago, he tested positive to HIV at a Melbourne clinic. On Monday, a spokesman at The Alfred confirmed researchers were "reviewing the clinical details of a man who has tested positive to HIV while being a registered participant of the Victorian PrEPX study."

    17 hours ago | The Age (Melbourne)
  • PrEP in the Transgender Population: New Study to Examine Effects

    Transgender women are a fast-growing and disenfranchised population of HIV-positive people in the United States, but few opportunities are available for transgender individuals to be involved in HIV research. Including the transgender community in HIV studies is necessary to design preventive and curative approaches that can be applied across the entire spectrum of genders.

    20 hours ago | Infectious Disease Advisor
  • United States: A GOP Health Care Plan May Ruin Our Best Chance At Ending HIV And AIDS

    Though it’s unclear how (or if) the ACA will be repealed, the plan passed by the House this month would certainly lead to fewer insured Americans and, by extension, fewer patients able to afford PrEP.

    17 May 2017 | Huffington Post
  • Teen PrEP program ramps up in San Francisco

    Three youth clinics of San Francisco Department of Public Health (SFDPH)—Cole Street Youth Clinic, Dimensions Queer Youth Clinic, and the Michael Baxter Larkin Street Youth Clinic—are providing comprehensive PrEP services for young people ages 12 to 24.

    11 May 2017 | BETA blog
  • Lib Dems say HIV prevention drug should be available on NHS

    Lib Dem health spokesman Norman Lamb said: "PrEP is a vital weapon in the fight against HIV, and it's high time that it was made routinely available to those who are at risk of infection."

    10 May 2017 | Evening Standard
  • Gilead slowly rolls out ads for Truvada for PrEP — 4 years after approval

    Gradually ramping up promotion of its HIV-prevention pill, Gilead Sciences has turned to humor, dating apps, and social-media sites like Tumblr and Snapchat to raise awareness about HIV prevention.

    08 May 2017 | Medical Marketing & Media
  • Kenya launches self-test kits and PrEP

    The Government of Kenya has reinforced its commitment to end AIDS by 2030 by launching two innovative technologies: self-testing for HIV and PrEP.

    05 May 2017 | UNAIDS
  • HIV, Vaginal Sex and PrEP Initiation: What Should You Tell Your Patients or Clients?

    This year, pre-exposure prophylaxis (PrEP) advocates noted a stunning disconnect between key organizations that issue guidelines on the use of tenofovir/emtricitabine (TDF/FTC, Truvada) for HIV prevention: The United States Centers for Disease Control and Prevention (CDC) continues to say that people need 20 days of daily TDF/FTC before they can consider themselves protected from vaginal HIV exposure -- but the World Health Organization (WHO) has stated that just seven days of the drug is enough.

    03 May 2017 | The Body Pro
  • IPM Advances Three-month HIV Prevention and Contraception Ring to Clinical Trial

    The three-month vaginal ring is designed to slowly — and simultaneously — release the antiretroviral drug dapivirine to prevent HIV and the contraceptive hormone levonorgestrel. The primary goal of the study, known as MTN-030/IPM 041, is to assess the ring’s safety and pharmacokinetics (how the body processes the two drugs). Results of the trial, including the product’s acceptability to women and their willingness to use it in the future, will inform next steps for the ring’s formulation and future trial designs.

    03 May 2017 | International Partnership for Microbicides
  • PrEP in Scotland: what next?

    Following the SMC’s decision to make PrEP available on the NHS in Scotland George Valiotis reflects on the work that made this possible and looks forward to the next steps.

    02 May 2017 | HIV Scotland
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.